Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

In drug-naïve subjects with type 2 diabetes ... The studies presented thus far therefore suggest that DPP-4 inhibition is an efficient treatment of type 2 diabetes, both as monotherapy and ...

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

which aims to anticipate and mitigate critical U.S. drug shortages of essential medicines through non-profit partnership.... HabitNu, a leader in preventive health, has expanded its Diabetes ...

Achieve Life Sciences, Inc. , a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, today announced ...

Below please find an overview of the most commonly used drugs for type 1 diabetes and type 2 diabetes. Click each drug to learn more information, including a list of the currently approved drugs in ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

The Director of Public Prosecutions PP today told the Nadi Magistrates Court that they intend to file summons against Fiji ...

A Magistrate's Court here has ordered the drug trafficking case involving a politician’s former research assistant to be ...

DPP Secretary General Kazuya Shimba said that Tamaki has his party’s full backing to stay on as leader after a report earlier Monday alleging marital infidelity. Shimba said the party will ...